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a b s t r a c t
Accurate knowledge of the ambient extracellular glutamate concentration in brain is required for understanding its potential impacts on tonic and phasic receptor signaling. Estimates of ambient glutamate
based on microdialysis measurements are generally in the range of 2–10 lM, approximately 100-fold
higher than estimates based on electrophysiological measurements of tonic NMDA receptor activity
(25–90 nM). The latter estimates are closer to the low nanomolar estimated thermodynamic limit of
glutamate transporters. The reasons for this discrepancy are not known, but it has been suggested that
microdialysis measurements could overestimate ambient extracellular glutamate because of reduced
glutamate transporter activity in a region of metabolically impaired neuropil adjacent to the dialysis
probe. We explored this issue by measuring diffusion gradients created by varying membrane densities
of glutamate transporters expressed in Xenopus oocytes. With free diffusion from a pseudo-inﬁnite 10 lM
glutamate source, the surface concentration of glutamate depended on transporter density and was
reduced over 2 orders of magnitude by transporters expressed at membrane densities similar to those
previously reported in hippocampus. We created a diffusion model to simulate the effect of transport
impairment on microdialysis measurements with boundary conditions corresponding to a 100 lm radius
probe. A gradient of metabolic disruption in a thin (100 lm) region of neuropil adjacent to the probe
increased predicted [Glu] in the dialysate over 100-fold. The results provide support for electrophysiological estimates of submicromolar ambient extracellular [Glu] in brain and provide a possible explanation
for the higher values reported using microdialysis approaches.
Ó 2014 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA license (http://
creativecommons.org/licenses/by-nc-sa/3.0/).

1. Introduction
During synaptic transmission, glutamate transporters restrict
the spatiotemporal pattern of ionotropic and metabotropic glutamate receptor signaling (for review see Tzingounis and Wadiche,
2007). In addition to their roles in shaping the dynamics of synaptically released glutamate, glutamate transporters also help maintain low steady-state glutamate levels. Given the stoichiometry of
ion coupling to glutamate uptake, the theoretical lower limit of
extracellular glutamate in brain is approximately 2 nM (Zerangue
and Kavanaugh, 1996; Levy et al., 1998). Many studies using intracerebral microdialysis have reported levels of ambient glutamate P 2 lM, three orders of magnitude higher than the
theoretical lower limit (Benveniste et al., 1984; Lerma et al.,
1986; for reviews see Cavelier et al., 2005; Nyitrai et al., 2006).
By contrast, reports of ambient glutamate concentration estimated
from electrophysiological measurement of tonic NMDA receptor
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activity in hippocampal slice range from 87 to 89 nM (Cavelier
and Attwell, 2005; Le Meur et al., 2007) to as low as 25 nM
(Herman and Jahr, 2007).
Accurate knowledge of the ambient glutamate concentration in
different brain regions is important for evaluating its effects on
synaptic transmission. Several ionotropic and metabotropic glutamate receptor subtypes are activated by low micromolar concentrations of glutamate, and tonic exposure in this range
profoundly inhibits synaptic circuitry in vitro (Zorumski et al.,
1996). Glutamate transporters play a dominant role in limiting
ambient glutamate, as pharmacological inhibition of transport
has been shown to lead to a rapid increase in ambient glutamate
causing increased tonic NMDA receptor signaling (Jabaudon
et al., 1999; Cavelier and Attwell, 2005; Le Meur et al., 2007;
Herman and Jahr, 2007).
In this work we attempt to integrate data in the literature with
new in vitro measurements and in vivo modeling of diffusion gradients formed by glutamate transporters. Proceeding from the
assumption that in steady-state conditions, the volume-averaged
rates of release and uptake of glutamate are equal, we show the
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inﬂuence of glutamate transporter membrane density on steadystate diffusion gradients in a density range relevant to in vivo brain
expression. We suggest that metabolic impairment of glutamate
transport in a shallow boundary region of a microdialysis probe
can account for the discrepancies between estimates of ambient
glutamate from dialysis and electrophysiological approaches.
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uðt; rÞ ¼ us when r > L

2. Materials and methods

This model cannot be solved analytically because of the nonlinear term in the right hand side of the equation, so it was solved
numerically by space discretization, which transforms it into system of ordinary differential equations. The leak rate constant (KL)
is related to ambient [Glu], volumetric glutamate transporter concentration [GluT] (140 lM, Lehre and Danbolt, 1998), transporter
KM value, and maximal turnover rate Jmax by the equation:

2.1. Xenopus oocyte recording

K L ¼ ½Gluambient =ðK m þ ½Gluambient Þ  ½GluT  J max

Approximately 50 ng of human EAAT3 cRNA was microinjected
into stage V–VI Xenopus oocytes and recordings were made 1–6 d
later. Recording solution contained 96 mM NaCl, 2 mM KCl, 1 mM
MgCl2, 1.8 mM CaCl2, and 5 mM Hepes (pH 7.5). Microelectrodes
were pulled to resistances between 1 and 3 MX and ﬁlled with
3 M KCl. Data were recorded with Molecular Devices ampliﬁers
and analog–digital converters interfaced to Macintosh computers.
Data were analyzed ofﬂine with Axograph X (v.1.0.8) and KaleidaGraph (v 3.6; Synergy) software. For stopped ﬂow measurements,
oocytes were voltage clamped at 60 mV in a perspex recording
chamber in which glutamate depletion in the absence of perfusion
was <1% of the total in the recording chamber. Transporter surface
density was estimated from current measurements assuming a
coupled current of 2 charges/cycle at ECl (20 mV), turnover rate
of 15/s, oocyte surface area 2.85  107 lm2, and transport voltage-dependance of e-fold/76 mV (Wadiche et al., 1995; Zerangue
and Kavanaugh, 1996). Current amplitudes were ﬁtted to the
Michaelis–Menten relationship:

I½Glu ¼ Imax ½Glu=fK M þ ½Glug
2.2. Mathematical modeling of [Glu] proﬁle near the microdialysis
probe
Our microdialysis probe model can be described by the following diffusion equation in polar coordinates with sink and source in
the right hand side:

@u=@t ¼ D  ð1=rÞ  @=@r ½r  @u=@r  J  u=ðK m þ uÞ þ K L
where u corresponds to L-glutamate concentration. The ﬁrst term in
the right hand side is a Laplace operator in polar coordinates multiplied by a diffusion coefﬁcient D. The second term represents
the Michaelis–Menten transport sink in the tissue, and the third
term KL represents the leak, which is treated as a constant. The
parameter J is a function of distance r from the probe center, and
describes the spatial dependence of transporter impairment
between the healthy and damaged tissue. The spatial metabolic
damage near the probe is approximated as a Gaussian curve, and
we deﬁne the function J as:

JðrÞ ¼ 0 when 0  r  L
2

JðrÞ ¼ J max  1  e^ ½ðr  LÞ2=2  sigma  when r > L
where L is the radial boundary for the microdialysis probe and
sigma represents the distance from the probe boundary characterizing the Gaussian damage function. The boundary conditions for
the model are:

@u=@rjr¼0 ¼ 0
uðt; 1Þ ¼ us
The initial condition is

uðt; rÞ ¼ u when 0  r  L

3. Results
3.1. Diffusive concentration gradients formed by glutamate
transporters
Co-expression studies of NMDA receptors with transporters for
its co-agonists glycine and glutamate have shown that transporters
can limit receptor activity by establishing diffusion-limited transmitter concentration gradients (Supplisson and Bergman, 1997;
Zuo and Fang, 2005). We studied the concentration gradients
formed by passive diffusion from a pseudo-inﬁnite glutamate
source in a perspex chamber to the glutamate sink established
by transporters on the cell surface. Oocytes expressing the human
neuronal glutamate transporter EAAT3 were voltage-clamped at
60 mV and superfused with varying concentrations of glutamate
at a linear ﬂow rate of 20 mm/s ﬂow followed by a stopped-ﬂow
interval (Fig. 1). Steady-state currents elicited by glutamate perfusion relaxed to a lower steady-state level when ﬂow was stopped,
and following resumption of ﬂow, currents rapidly recovered to
initial values. The reduction in current amplitude during zero ﬂow
conditions was likely due to the formation of a diffusion-limited
concentration gradient resulting in reduced surface [Glu], because
the ratio of the current amplitudes with and without ﬂow were
dependent on the concentration of glutamate in the perfusate,
and in all cases the amount of glutamate transported was <1% of
the total glutamate in the chamber (i.e. a pseudo-inﬁnite glutamate source; Fig. 1B–D). This gradient was also reﬂected in a signiﬁcant shift in the concentration-dependance of steady-state
currents in ﬂow and stopped-ﬂow conditions (KM value for L-glutamate of 32 ± 2 and 216 ± 37 lM, respectively, n = 4; p < 0.002),
while the Imax values were not signiﬁcantly different.
3.2. Transporter density inﬂuence on kinetic parameters
Glutamate transporters are expressed at different densities
among structures in the CNS, and transporter density and/or kinetics can be altered in different pathological circumstances such as
trauma and ischemia. Because steady-state ambient [Glu] reﬂects
a homeostatic balance of uptake and leak sources, changes in
transport may result in signiﬁcantly different steady state glutamate levels. We tested the inﬂuence of the surface density of glutamate transporters on the concentration gradient formed by
passive glutamate diffusion during stopped-ﬂow experiments by
monitoring currents induced by 10 lM glutamate. With increasing
transporter expression levels, the steepness of the concentration
gradient formed during stopped-ﬂow conditions was increased,
as reﬂected in the changing ratio of the steady-state currents in
ﬂow and stopped-ﬂow conditions (Fig. 2A and B).
Even with continuous ﬂow, evidence for formation of a concentration gradient between the cell surface and bulk solution was
observed. Oocyte membranes have a microvillar structure that
can act as tortuous diffusion barrier (see Supplisson and
Bergman, 1997). In a group of 29 oocytes with varying expression
levels, steady-state KM values measured with chamber ﬂow
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Fig. 1. Glutamate transport acts as a sink to form a concentration gradient between the extracellular volume and the membrane surface. (A) Current induced by 10 lM
glutamate decays to a lower steady state ﬂow under stopped-ﬂow conditions at 60 mV. (B) Current responses to varying [Glu] with and without ﬂow at 60 mV. (C)
Glutamate concentration-dependance of steady-state currents in ﬂow and stopped-ﬂow conditions. (km value with ﬂow: 32 ± 2 lM; stopped-ﬂow: 215 ± 37 lM; n = 4,
p = 0.0014). (D) Glutamate concentration-dependance of the ratio of current amplitudes in stopped-ﬂow and ﬂow conditions.
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Fig. 2. Glutamate concentration gradients are a function of transporter density. (A) Representative traces of stopped-ﬂow experiments with oocytes expressing different
transporter densities. (B) Currents from cells in (A) normalized to the steady state current. (C) Glutamate concentration-dependance of steady-state currents with low,
medium and high expression levels. (km values: low expression: 33 lM, medium expression: 50 lM and high expression: 98 lM. Transport current amplitudes (1 mM
glutamate) are 260, 332 and 688 nA, respectively). (D), KM values from 29 oocytes with different expression levels (ﬁtted with linear regression, r = 0.78; y
intercept = 26.8 lM).
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(20 mm/s) increased approximately 4-fold as transporter current
induced by 1 mM glutamate increased from 200 to 1100 nA
(Fig. 2C and D). Thus, there is an effect of the concentration gradient formed by transporters even with continuous ﬂow, resulting in
a discrepancy between the measured and actual glutamate KM
value. We extrapolated a linear function relating the measured
KM value to the transport current density (Barry and Diamond,
1984), yielding an estimate of the intrinsic KM value of approximately 27 lM (r = 0.78; Fig. 2D).
3.3. Surface [Glu] as a function of transporter density
While the dependance of steady-state KM on transporter density
reﬂects the fact that the true glutamate concentration at the cell
surface is reduced by uptake, the concentration difference associated with the diffusion gradient is minimal at when high concentrations of glutamate are applied by continuous ﬂow. In oocytes
expressing varying densities of transporters, we recorded currents
induced by superfusion of 1 mM glutamate in order to generate
the theoretically predicted current amplitude in each cell as a function of [Glu] from the Michaelis–Menten function using the intrinsic KM value of 27 lM (Fig. 3A). We then recorded the actual steadystate current amplitude in each cell in response to 10 lM glutamate
under stopped-ﬂow conditions and compared these to the values
predicted by the Michaelis–Menten function. There was a discrepancy between the theoretically predicted and measured values,
and this difference increased monotonically with transporter density. We inferred the actual glutamate surface concentration in
the stopped-ﬂow condition with 10 lM glutamate in the chamber
from the measured current amplitudes using the uniquely determined Michaelis–Menten function for each cell (Fig. 3A and inset).
The inferred surface concentration was then plotted as a function of
transporter density. There was a supralinear effect of transporter
density on surface [Glu] in stopped-ﬂow conditions (Fig. 3B). Transporter density in this group of cells ranged from 234 to 5165 transporters per lm2. At low expression levels, the estimated [Glu]
approached the 10 lM source concentration. However, at transporter densities of 5000 lm2 (compare with estimates in hippocampus of 10,800 lm2; Lehre and Danbolt, 1998), surface [Glu]
was estimated to be reduced to 50 nM, roughly 200-fold lower.
3.4. Modeling the glutamate concentration proﬁle near a microdialysis
probe
We constructed a diffusion model to simulate the spatial proﬁle
of glutamate near a microdialysis probe (see Section 2). From

quantitative immunoblotting, the glutamate transporter density
in hippocampus has been estimated to be between 0.14 and
0.25 mM (Lehre and Danbolt, 1998). From the transporter density,
glutamate transport averaged over a given volume of neuropil can
be estimated for any given ambient glutamate value based on
Michaelis–Menten kinetics (neglecting exchange, which becomes
signiﬁcant near the equilibrium thermodynamic limit). At steady
state, sources and sinks are equal, and the steady-state leak and
uptake of glutamate are equal. With ambient [Glu] = 25 nM (Herman and Jahr) and using the lower transporter density estimate
of 0.14 mM (Lehre and Danbolt, 1998), the volume-averaged
steady-state glutamate leak is predicted to be approximately
2100 molecules lm3 sec1 (but see Cavelier and Attwell, 2005).
This tonic leak will cause increased ambient glutamate if transport
is reduced, as could occur in a metabolically impaired region of
neuropil near a microdialysis probe (Benveniste et al., 1987;
Clapp-Lilly et al., 1999; Amina et al., 2003; Bungay et al., 2003;
Jaquins-Gerstl and Michael, 2009). We used the diffusion model
to describe the spatial proﬁle of [Glu] near a 100 lm radius microdialysis probe with an adjacent damaged region described by a
Gaussian gradient of impaired transport (Fig. 4A). Although transporter reversal can occur with severely impaired ion gradients, we
neglected this effect, which may underestimate effects of metabolic damage on glutamate measured in the probe. Starting the
simulation at time = 0 with no glutamate in the interior of the
probe, the glutamate concentration rises with an exponential time
constant  8.5 s to a steady state level (data not shown). At steady
state, [Glu] inside the probe is elevated relative to the healthy
region far from the probe (Fig. 4B1). With sigma = 0 (i.e. no tissue
damage), [Glu] in the probe is equal to the ambient [Glu] in the
healthy tissue. With gradients of damage from sigma = 100 to
300 lm, steady-state glutamate levels in the probe range from
3 to 10 lM (Fig. 4B1). Decreasing the glutamate diffusion coefﬁcient from its value in buffer, which is higher than in brain
(Kullmann et al., 1999), increases the predicted steady state [Glu]
measured in the probe (Fig. 4B2). Increasing or decreasing the leak
rate L (Fig. 4B3) also inﬂuences steady state [Glu] predicted in the
probe volume.
4. Discussion
Glutamate transporters limit receptor activity on different time
scales in the brain by restricting the spread of synaptically released
glutamate as well as by maintaining low ambient glutamate concentrations (for reviews, see Danbolt, 2001; Tzingounis and
Wadiche, 2007; Vandenberg and Ryan, 2013). The steady-state
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glutamate (µM)
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B
normalized current amplitude

normalized current amplitude

A

149

transporter density (µm-2)

Fig. 3. Surface [Glu] estimates as a function of transporter density. Surface [Glu] estimated from relative amplitude of steady state current amplitude without ﬂow to the
1 mM steady state glutamate current with ﬂow ﬁtted to Michaelis–Menten function (KM = 26.8 lM) (A, semi-log plot; inset, double-log plot) and plotted as a function of
transporter density (B) for each oocyte at 60 mV.
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Fig. 4. Diffusion model of transporter contribution in dialysis measurement. (A1) Cartoon of metabolic damage in Gaussian region surrounding the microdialysis tube. (A2)
Reduced uptake rate described by the Gaussian function in the damaged region. (B) PDE numerical modeling describing the spatial proﬁle of steady-state [Glu] with varying
sigma (B1), diffusion constant (B2) and leak rate (B3).

ambient concentration of extracellular glutamate at any point in
brain reﬂects the balance of ﬂuxes through sources and sinks in
the neuropil. The data presented here indicate that transporters
can establish steep concentration gradients when glutamate is
supplied by passive diffusion from a pseudo-inﬁnite source.
Although we have used the neuronal transporter EAAT3 in these
studies, its equilibrium thermodynamics are indistinguishable
from the predominant astroglial transporter EAAT2 (Levy et al.,
1998). With EAAT3 transporter densities similar to those reported
for EAAT2 in hippocampal astroglial membranes (104/lm2; Lehre
and Danbolt, 1998) the concentration gradient between a 10 lM
source concentration and the cell surface was found to exceed
two orders of magnitude. The steepness of the gradient formed
would be further increased if diffusion were reduced, as for example in tortuous neuropil (Kullmann et al., 1999). Conversely, reduction of transporter density or activity will reduce the steepness of
the gradient and increase [Glu] at the cell surface. Reduced glutamate transport by loss or metabolic impairment is implicated in
a broad range of neurodegenerative disorders (Sheldon and
Robinson, 2007) including stroke (Rossi et al., 2000), traumatic
brain injury (Goodrich et al., 2013), epilepsy (Coulter and Eid,
2012), Huntington’s disease (Faideau et al., 2010), ALS (Rothstein,
2009), and Alzheimer’s disease (Scimemi et al., 2013).
While a precise knowledge of the concentration of ambient glutamate in various brain regions in normal and neuropathological
conditions is desirable, reports of this value in the literature vary
widely, with microdialysis approaches consistently providing estimates approximately two orders of magnitude greater than estimates based on electrophysiological measurement of tonic
glutamate receptor activity. In the absence of transporter inhibition, ambient [Glu] has been reported as being too low to activate
AMPA receptors, even when desensitization is pharmacologically
blocked (Le Meur et al., 2007). In contrast, ambient [Glu] has been
reported to tonically activate high-afﬁnity NMDA receptors (Sah

et al., 1989; Cavelier and Attwell, 2005; Le Meur et al., 2007;
Herman and Jahr, 2007). Several patch clamp studies in acute hippocampal slice have provided estimates of ambient [Glu] based on
analyses of the tonic NMDA receptor currents in CA1 pyramidal
neurons. These have been reported as 25 nM at 32° (Herman
and Jahr, 2007), 27–33 nM at 25° and 77–89 nM at 35° (Cavelier
and Attwell, 2005), and 83–87 nM at 25° (Le Meur et al., 2007).
These estimates are not likely to be artifactually low due to loss
of glutamate from the surface of the slice, because inclusion of
2 lM glutamate in the recording chamber did not alter the level
of tonic receptor activity (Herman and Jahr, 2007). The major
source of glutamate in these studies was of non-vesicular origin.
A range of possible molecular mechanisms may underlie glutamate
release, including glutamate-permeable anion channels, the cystine-glutamate exchanger xCT, and passive membrane diffusion
(Kimelberg et al., 1990; Baker et al., 2002; Cavelier and Attwell,
2005; for review see Cavelier et al., 2005). Elevation of ambient
[Glu] by inhibition of glutamine synthetase suggests that a major
contribution of glutamate release is from glia (Cavelier and
Attwell, 2005; Le Meur et al., 2007).
The data and the diffusion model presented here suggests that a
thin layer of damaged tissue with disrupted glutamate transport
could underlie the signiﬁcant quantitative discrepancy between
the ambient glutamate estimates provided by electrophysiological
studies in slices and those from microdialysis studies, which generally report ambient [Glu] values in the range P2 lM (reviewed
by Cavelier et al., 2005; Featherstone and Shippy, 2008). Histological analyses of tissue surrounding microdialysis probes provide
evidence for a layer of damaged tissue up to hundreds of microns
surrounding the probe (Clapp-Lilly et al., 1999; Bungay et al.,
2003; Amina et al., 2003; Jaquins-Gerstl and Michael, 2009). Diffusion modeling suggests that disrupted transport in this region
could lead to artifactually large concentrations in the probe volume. A critical assumption in our model is that the glutamate leak
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source is constant in a volume of metabolically damaged tissue
where transport is impaired. The precise spatial changes in metabolic activity in a traumatized or ischemic region of tissue are
unknown, but the assumption that the leak is constant is conservative. For example, glutamate release is increased by reversed glutamate transport due to impaired Na/K gradients during metabolic
challenge (Rossi et al., 2000). With a spatial distribution of transporter impairment modeled with a Gaussian distribution, sigma
values as small as 100 lm lead to signiﬁcant elevation of predicted
probe [Glu] (Fig. 4B1).
In addition to pharmacological block of glutamate uptake leading to increased activation of AMPA and NMDA receptors
(Jabaudon et al., 1999, 2000; Cavelier and Attwell, 2005; Le Meur
et al., 2007; Herman and Jahr, 2007), ischemia-induced reversed
transport also leads to large increases in extracellular [Glu] and
pathological receptor signaling (Rossi et al., 2000). Changes are also
predicted by the probe diffusion model probe as a consequence of
increases in basal glutamate release (Fig. 4B3). While the value of
extracellular [Glu] in the probe dialysate is predicted to signiﬁcantly exceed ambient [Glu] in healthy tissue far from the probe,
the dialysate concentration is also predicted to change in approximate proportion to changes in glutamate homeostasis in distant
tissue (Fig. 4B3). This behavior of the model is consistent with
reported changes in dialysate [Glu] in response to factors including
transport block, ischemia, and trauma (Benveniste et al., 1984;
Hagberg et al., 1985; Baker et al., 2002; Del Arco et al., 2003;
Nyitrai et al., 2006).
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